← Leaderboards
James W Shih
Clinical Center
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Center
Same institution · by research overlap
Others in their field
Top investigators on “Polymerase Chain Reaction”
- Richard A Gibbs · Baylor College Of Medicine$161,803,490
- Norman Wolmark · Nsabp Foundation, Inc.$79,506,229
- David Heimbrook · Leidos Biomedical Research, Inc.$70,580,438
- Constance Ann Benson · University Of California, San Diego$66,635,731
- Eric S Lander · Whitehead Institute For Biomedical Res$52,964,838
- Thomas William Geisbert · Boston University Medical Campus$36,787,680
Research focus
Polymerase Chain ReactionHepatitis C VirusCommunicable Disease DiagnosisDiagnosis Design /EvaluationHuman Immunodeficiency VirusHepatitis CDiagnosis Quality /StandardCommunicable Disease ControlVirus GeneticsHiv InfectionsVirus ClassificationDiagnostic TestsMycoplasmaBacterial DiseaseHepatitis VaccineSerology /SerodiagnosisLaboratory MouseElectron MicroscopyHepatitis B Virus GroupHuman TissueClinical ResearchHepatitisMethod DevelopmentActive Immunization
Grant awards (16)
Characterization Of Newly Identified Viral Genomes And T$0
Z01 · FY2003 · CL
Characterization Of Human Pathogenic Mycoplasma From Hiv$0
Z01 · FY2003 · CL
Molecular Testing Standards And New Amplification Approa$0
Z01 · FY2003 · CL
Evaluation Of Nucleic Acid Vaccine As A Preventive And T$0
Z01 · FY2003 · CL
Characterization Of Newly Identified Viral Genomes And T$0
Z01 · FY2002 · CL
Evaluation Of Nucleic Acid Vaccine As A Preventive And T$0
Z01 · FY2002 · CL
Molecular Testing Standards And New Amplification Approa$0
Z01 · FY2002 · CL
Characterization Of Human Pathogenic Mycoplasma From Hiv$0
Z01 · FY2002 · CL
Human Pathogenic Mycoplasma From Hiv-infected Patients$0
Z01 · FY2001 · CL
Characterization Of Newly Identified Viral Genomes$0
Z01 · FY2001 · CL
Nucleic Acid Vaccine: Prevention and Therapy$0
Z01 · FY2001 · CL
Molecular Testing Standards/New Amplification Methods$0
Z01 · FY2001 · CL
Characterization of Newly Identified Viral Genomes and Their Clinical Correlatio$0
Z01 · FY2000 · CL
HUMAN PATHOGENIC MYCOPLASMA FROM HIV INFECTED PATIENTS$0
Z01 · FY2000 · CL
MOLECULAR TESTING STANDARDS AND AMPLIFICATION APPROACHES$0
Z01 · FY2000 · CL
Evaluation of Nucleic Acid Vaccine as a Preventive and Therapeutic Modality$0
Z01 · FY2000 · CL